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Abstract
The present study investigated the utility of the MMPI-2-Restructured Form
(MMPI-2-RF) over-reporting scales (F-r, Fp-r, Fs, and FBS-r) and the Response Bias
Scale (RBS) to detect symptom exaggeration among litigants claiming chronic pain.
Utilizing the Bianchini et al. (2005) multi-method criteria for Malingered Pain Related
Disability (MPRD), patients were classified along a continuum ranging from incentive
only to definite malingering. Malingering classification was found to have a significant
effect on MMPI-2-RF over-reporting scales, particularly the RBS, Infrequent Symptoms
Scale (F-r), and Infrequent Somatic Responses scale (Fs), which supports the use of the
MMPI-2-RF in forensic disability evaluations.
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Chapter I
Introduction
Each year, disability fraud costs the United States approximately 6 billion dollars
(ABC News, May, 2006) and individuals claiming to experience symptoms of chronic
pain make up a portion of these costs. It is the responsibility of physicians to make
difficult decisions regarding a claim of disability, and often times, psychologists are
called upon to provide objective testing in order to evaluate the legitimacy of an
individual’s claims. It is important that aids to the reduction of this growing economic
problem be researched and validated.
Introduction to Response Styles
Many psychological, somatic, and cognitive dysfunctions are predominately
experienced internally. Consequently, they can best be measured by self-report methods.
Indeed, self-report measures are the most widely used and researched personality and
psychopathology assessment methods (Ben-Porath, 2003). However, while self-report is
in some cases the sole method to obtain information on the internal experiences of an
individual; these measures are not without their limitations. When relying on the selfreport of a test-taker, assessing the validity of the results is a necessary component to the
evaluation. External influences can include the stressful and financial effects of litigation,
as well as pressure from attorneys, family members, or other individuals of interest
(Rogers & Bender, 2003). Internal influences on self-report, on the other hand, can
involve effects of a genuine disorder, a reaction to questioned integrity, the stigmatization
of mental and physical disorders and disabilities, or the effort of the individual to obtain
undeserved incentive (Rogers & Bender, 2003).
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These internal and external influences during test-taking can produce an invalid
protocol on a self-report measure. Protocol validity is the degree to which an examinee’s
responses on a psychological test are an accurate representation of his or her
symptomatology. Ben-Porath (2003) discussed two broad threats to the protocol validity
of a self-report inventory: non-content and content based invalid responding. Non-content
based invalid responding is characterized by an individual’s responses being based on
something other than the accurate reading, processing, and comprehension of the test
items (e.g. random responding). Content-based invalid responding, on the other hand, is
characterized by the intentional distortion of test results by the test taker. Individuals
undergoing psychological assessments, particularly in forensic settings, may intentionally
distort their psychological characteristics in order to alter assessment results and portray
themselves in an unrealistic fashion. When an individual undergoing a psychological
assessment intentionally skews his or her results on the measure, resulting in a misleading
representation, that individual is said to exhibit content-based invalid responding, or
response bias.
Ben-Porath (2003) also discusses the two types of content-based invalid
responding: over-reporting and underreporting. The over-reporting of symptoms occurs
when an individual reports exaggerated symptoms or symptoms that do not exist.
Underreporting is the opposite; it occurs when an individual lessens his or her symptoms
or denies that symptoms exist completely. An individual may distort his or her symptoms
for many different reasons. On one hand, he or she may portray his or her level of
adjustment in a very positive light in order to appear more appealing to a future employer
or in order to appear better fit to obtain custody of children in a parental fitness
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evaluation. On the other hand, an individual may distort him or herself in order to appear
more impaired, whether it is for attention-based purposes or for a more tangible
incentive, such as monetary compensation in a civil suit or a lesser criminal sentence in
light of a diagnosis of a mental illness (e.g., an insanity defense).
Going beyond the dichotomous classifications of over-reporting or underreporting
presented by Ben-Porath (2003), Rogers (2008) identified four separate types of response
bias: nonspecific terms, overstated pathology, simulated adjustment, and other response
styles, the first three of which will be discussed here. The first of these types, nonspecific
terms, is a general response style that entails the degree to which an individual’s response
pattern contains unreliability, nondisclosure, self-disclosure, deception, or dissimulation.
This response style is a much more general assumption about a pattern of responses than
a style such as malingering or factitious presentations, both of which involve the
intentional production of symptoms or symptom exaggeration (APA, 2000). This type
simply asserts that the information is invalid, and does not also assume the intention of
the individual behind the invalidation. Unreliability refers to the accuracy of the
information presented by the individual, nondisclosure is the amount of information the
individual has withheld, self-disclosure is the amount of information presented by the
individual about him or herself, deception is the individual’s attempt to distort his or her
self-representation, and dissimulation is the purposeful distortion by the individual of his
or her psychological symptoms.
Overstated pathology, the second of the over-reporting styles presented by Rogers
(2008) includes three subtypes. Beginning with the most general of these subtypes,
feigning is the exaggeration or fabrication of psychological and/or physical symptoms,
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without any assertion as to the motive behind this exaggerated or fabricated response
pattern. Factitious presentation, the second subtype, is identified by an individual’s
intentional invention of physical or psychological symptoms in order to assume a sick
role (APA, 2000). Finally, malingering, which will be more thoroughly addressed later is
the intentional exaggeration or production of physical or psychological symptoms,
motivated by an external incentive (APA, 2000).
Defensiveness, social desirability, and impression management are the three
subtypes of the simulated adjustment response style, the third of the response styles
presented by Rogers (2008). Again beginning with the most general of these styles,
impression management is defined as an individual’s intentional attempt to affect the
opinions others have of him or her, without assumption of the individual’s motive for this
desired perception. Defensiveness is the deliberate attempt to minimize or deny
psychological and/or physical symptoms. The third impression management style, social
desirability, is characterized by the individual attempting to present him or herself in the
most positive light, which can involve the denial of any presumed negative qualities and
the attribution of perceived positive or socially desirable qualities.
Malingering
The DSM-IV-TR defines malingering as “the intentional production of false or
grossly exaggerated physical or psychological symptoms, motivated by external
incentives such as avoiding military duty, avoiding work, obtaining financial
compensation, evading criminal prosecution, or obtaining drugs” (APA, 2000, p. 739).
As suggested in the DSM-IV-TR definition, malingering can become a substantial
concern in many circumstances, including obtaining medication, work or military
4

avoidance, and when a case concerns the potential for evading criminal prosecution, or
financial incentive, as in disability cases.
Bender (2008) states that malingering falls into four subtypes, ranging from
transference to the more extreme type, invention. Transference is a type in which an
individual has problematic symptoms, yet they are not related to or affected by the
symptoms currently being claimed by that individual. Secondly, there is exaggeration, in
which, as the name suggests, the individual does in fact have the symptoms presented,
but the individual has amplified their severity. Preservation is the third type, wherein an
individual once had the actual symptoms he or she is claiming, however the symptoms
have since dissipated and the individual is feigning their continuance. The fourth and
final type of malingering is invention, a type in which the individual does not have and
has never had the symptoms which he or she is claiming; the symptoms are completely
fabricated.
Malingering, regardless of its type, has been found to have high rates within
assessment, particularly forensic assessment. A base rate is the number which represents
the projected prevalence for a condition within a given population. The prevalence, or the
base rate, of malingering varies from study to study and within different referral
circumstances (medical, criminal, civil, disability, etc.). Mittenberg, Patton, Canyock, and
Condit (2002) collected surveys from 131 members of the American Board of Clinical
Neuropsychology (ABCN), which estimated the percentage of probable malingering
cases within their practices to range from 8% to 31% across various types of clinical
settings. Much of this wide range is due to the range of referral circumstances for which
malingering would be assessed. The base rate of malingering in, for example, a chronic
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pain setting is different than the base rate of malingering in head injury claims. For
instance, it has been estimated that probable malingering has base rates of 39% in mild
head injury claims, 35% with fibromyalgia/chronic fatigue, 31% of chronic pain, 27% of
neurotoxic, and 22% of electrical injury claims (Mittenberg, Patton, Canyock, & Condit,
2002). While varying studies report slight variations of these estimates due to differing
domains and referral questions, each study presents an estimated base rate that suggests
the importance of the accurate detection of malingering, regardless of the referral
circumstances. Overall, if malingering measures were to be administered in all referrals,
it is estimated that the base rate would fall between 10-30% (Rogers, 2008).
Relevance to Forensic Psychology
Malingering is an issue of particular importance in a forensic setting.
Psychologists are often called upon to provide psychological assessments in civil and
criminal cases. In a civil case, financial stakes can be extremely high, giving any
involved individual incentive to feign or exaggerate symptoms (Wygant, Ben-Porath,
Arbisi, Berry, Freeman, & Heilbronner, 2009). A psychologist utilizing assessment
measures is able to provide the legal system with an objective measure of an individual’s
probability of malingering. Given that forensic psychology is a context in which much is
typically at stake for an individual undergoing a psychological assessment, the
assessment measures for malingering becomes an integral clinical consideration for any
forensic assessment battery. Though base rates of malingering in forensic settings vary,
each estimate identifies a significant minority of individuals who fall into a probable or
definite malingering category (Mittenberg, Patton, Canyock, & Condit, 2002), which can
have a significant effect on the judicial system.
6

In regards to disability claims, financial incentive produces a major influence on
the rates of malingering. According to the National Insurance Crime Bureau, in the first
quarter of 2009, worker’s compensation fraud increased 71% from the previous year
(Florida Department of Financial Services, 2009). An accurate and efficient method of
malingering detection in these situations is important so as to prevent individuals
malingering their symptoms from obtaining health care resources that would be more
deserved by individuals who have genuine substantial disabilities (Bianchini, Greve, &
Glynn, 2005).
DSM Diagnosis
It has long been recognized that the Diagnostic and Statistical Manual from the
American Psychiatric Association (DSM; APA, 2000) provides little guidance in
assessing malingering (see Rogers, 2008 for extensive discussion of this topic). While the
DSM provides an accurate definition of what malingering entails, it does not provide
clinicians and researchers with an objective and measureable method to systematically
diagnose when it occurs. Currently classified as a V-code under Additional Conditions
That May Be a Focus of Clinical Attention, malingering, as defined in the DSM-IV-TR,
lacks criteria to diagnose this problematic clinical behavior. While the DSM-IV-TR does
list conditions under which malingering should be suspected and thus assessed (APA,
2000), these conditions do not assist a clinician on how to assess for malingering when
the mentioned conditions have been met. Even the use of the DSM-IV-TR in screening
individuals for possible malingering has failed entirely. In fact, in a criminal forensic
screening, use of the DSM-IV-TR malingering criteria alone has rendered a false-positive
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rate of around 80% (Rogers, 1990), suggesting this lack of DSM-IV-TR criteria is a
significant problem.
Alternative Diagnostic Criteria
It is due to this lack of criteria that separate and more specific diagnostic criteria
outside of the DSM-IV-TR system have been established, most notably the diagnostic
criteria of Slick et al. (1999) and Bianchini et al. (2005) (utilized later in this study). Slick
and colleagues (1999) responded to this growing problem of a lack of measureable and
systematic criteria by establishing their own diagnostic criteria to detect malingered
neurocognitive dysfunction (MND). Following the lead of these researchers, Bianchini
and colleagues (2005) later established related criteria to detect malingered pain related
disability (MPRD). Each list of proposed criteria is used to assess the degree of symptom
feigning, ranging from possible malingering, to probable malingering, to definite
malingering.
Prior to the publication of the Bianchini et al. criteria, malingered pain was
assessed using the Slick et al. MND criteria. For instance, Etherton and colleagues (2005)
used the Slick et al. criteria in a study determining the sensitivity and specificity of the
Reliable Digit Span measure in assessing malingered pain.
Although the Slick et al. criteria have been applied in malingered pain studies, the
symptoms evaluated in these studies are limited to cognitive impairment complaints. The
later established Bianchini et al. criteria addressed this problem with the development of
specific criteria for identifying MPRD. These criteria are a potential asset in a medicolegal context, as MPRD has been found to be a prevalent issue. In fact, among pain
patients, the most reliable estimates of malingered disabilities are between 20%-40%
8

(Greve, Ord, Bianchini, & Curtis, 2009). The growing trends of disability related to
chronic pain are reflective of an epidemic (Melhorn, Lazarovic, & Roehl, 2009), making
the accurate detection of MPRD an important clinical and social issue. The development
of the Bianchini et al. criteria enables clinicians to make determinations regarding the
possibility to malingering specifically in the domain of these physical symptom
complaints.
The MPRD have already been examined with the Minnesota Multiphasic
Personality Inventory-2 (MMPI-2). Bianchini and colleagues (2008) utilized the MPRD
criteria in order to determine the accuracy of the validity scales included on the MMPI-2
in detecting malingered pain-related disability. Individuals classified as definite MPRD
were found to have higher scores on the MMPI-2 over-reporting validity scales in
general. Specifically, FBS and Fb were found to have the largest effect sizes in
distinguishing individuals who were malingering from those determined to respond
honestly.
As previous research has shown, the Slick et al. (1999) and the Bianchini et al.
(2005) criteria may be considered a suitable addition to the use of the definition of
malingering presented in the DSM-IV-TR (APA, 2000) in the diagnosis of malingered
pain related disability and malingered neurocognitive dysfunction. Each of these sets of
criteria provides an assessor with the tools to objectively measure the possibility of
malingering. With criteria regarding performance on neuropsychological measures
(particularly symptom validity tests) and evidence obtained from self-report measures, a
clinician is able to form a more distinct picture of that individual’s probability of
malingered pain related disability or neurocognitive dysfunction. The two sets of criteria
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even allow the assessor to determine different levels of malingering, indicating the
likelihood of malingered symptomatology. While the DSM-IV-TR presents criteria that
are very broad, subjective, and open to the clinician’s interpretation, the Bianchini et al
and the Slick et al criteria enable the clinician to place an individual in one of three
categories of malingering by use of performance on valid and reliable assessment
measures.
Domains of Malingering
Feigning, and in particular, malingering can be broken down into three domains.
These domains are psychopathology, neurocognitive dysfunction, and physical/somatic
dysfunction. Any particular individual’s response bias may not be limited to one domain
within malingering. An examinee attempting to misrepresent him or herself may attempt
to feign symptoms which fall within any combination of the three domains. For example,
an individual reporting chronic pain may also present with decreased performance on
measures used to detect cognitive dysfunction. Research by Burchett and Ben-Porath
(2010) has shown this through the use of the self-report personality inventory, the
Minnesota Multiphasic Personality Inventory-2- Restructured Form (MMPI-2-RF;
Tellegen & Ben-Porath, 2008). Their research demonstrated that individuals instructed to
feign symptoms of psychopathology not only obtained the highest scores on scales
measuring psychological dysfunction, but also scored highest (in some cases significantly
higher than the somatic feigning simulation group) on scales designed to measure somatic
symptoms.
Reported base rates for malingering differ across these three different domains.
Within the psychological dysfunction domain, researchers have estimated that up to 20%
10

of criminal forensic cases and 30% of civil forensic cases involve over-reporting of
psychological symptoms (Mittenberg, Patton, Canyock, & Condit, 2002; Rogers, Salekin,
Sewell, Goldstein, & Leonard, 1998; Rogers, Sewell, & Goldstein, 1994). Within the
physical/somatic domain, the base rates for malingering among chronic pain patients
ranges from 20-50% (Greve et al., 2009). In addition, Greve and colleagues (2009) found
that, though the majority of pain patients in their sample did not meet the full criteria for
malingering, nearly half of the sample exhibited some evidence of symptom exaggeration
on symptom validity measures. Finally, within the domain of cognitive dysfunction,
malingering base rates in mild head injuries cases have been found to fall between 3841% (Mittenberg, Patton, Canyock, & Condit, 2002).
Detecting Response Bias and Malingering
Each domain of malingering will have a different clinical presentation, and so,
each domain in turn has varying detection strategies (Rogers & Bender, 2003). As would
be expected, there are different validity measures designed to detect the malingering of
psychological symptoms than those designed to detect the malingering of somatic
symptoms. However, as previously stated, malingering individuals may present
symptoms falling in multiple domains, so examinees should be administered detection
measures representative of each domain in which the individual is suspected to be
malingering.
Detection of Feigned Psychological Symptoms
The detection of feigned psychological symptoms typically involves the use of
self-report measures and structured interviews. Given that psychological and psychiatric
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symptoms represent internal experiences that need to be expressed through self-report,
the premise of most methods for detecting malingering in this domain is that the
individual will report experiences that are inconsistent with a genuine or common
representations of mental illness (Wygant, 2007). Rogers (2008) identified several
methods utilized in the detection of feigning. These methods employ the use of
indentifying rare symptoms, quasi-rare symptoms, improbable symptoms, symptom
combinations, spurious patterns of psychopathology, indiscriminant symptom
endorsement, symptom severity, obvious symptoms, reported versus observed symptoms,
and erroneous stereotypes. In identifying those preceding aspects of an individual’s
responses, assessors can see the endorsement of symptoms that are rarely and not likely
to be claimed by genuinely mentally ill individuals, unlikely symptom combinations,
symptoms which are not supported by the observed behavior of the individual, or
symptoms that are endorsed due to a false stereotype about symptoms of the mental
illness an individual is attempting to feign.
Several personality inventories have built-in validity scales in order to detect
response bias. There are in fact two widely used inventories that have been shown to
accurately detect response bias and, in particular, over-reporting. The Minnesota
Multiphasic Personality Inventory-2 (MMPI-2; Butcher, Graham, Ben-Porath, Tellegen,
Dahlstrom, & Kaemmer, 2001), which will later be addressed in detail, and the
Personality Assessment Inventory (PAI; Morey, 1991, 2007), both of which have built-in
validity scales which can be used to detect feigning (Rogers & Bender, 2003). Most of
the built-in validity scales in these personality measures use the rare or unlikely symptom
approach to determine if an individual’s personality profile is exaggerated.
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In addition to personality inventories with built-in validity scales, there have also
been separate validity measures, in the form of structured interviews, specifically aimed
to detect malingering, two of which are aimed toward detecting feigned psychological
dysfunction. The Structured Interview of Reported Symptoms (SIRS; Rogers, Bagby, &
Dickens, 1992) uses each of the detection methods discussed by Rogers (2008), with the
exception of erroneous stereotypes (Rogers & Bender, 2003). Used for the systematic
assessment of malingered mental disorders, the SIRS classifies interviewees into three
categories: feigning, indeterminate, and non-feigning (Rogers, Bagby, & Dickens, 1992).
Its most recent version, the Structured Interview of Reported Symptoms-Second Edition
(SIRS-2; Rogers, Sewell, & Gillard, 2010) breaks the continuum down even further by
classifying individuals into four categories: genuine responding, indeterminate-general,
indeterminate-evaluate, and feigning. The Miller Forensic Assessment of Symptoms Test
(M-FAST; Miller, 2001) is a structured 25-item screening measure validated to assess for
malingered psychopathology. Through the use of seven different scales it utilizes several
of the methods identified by Rogers (2008), including reported versus observed
symptoms, symptom severity, and rare combinations. In addition, however, this measure
also includes a suggestibility item, which in known groups of individuals with genuine
psychopathology was never endorsed (Miller, 2001).
Finally, there is also a self-administered multi-axial inventory, the Structured
Inventory of Malingered Symptomatology (SIMS; Widows & Smith, 2005), that is used
to detect not only symptom feigning in the psychological domain, but also in the
neurocognitive domain. This 75-item screening measure utilizes five different scales
measuring feigned psychosis, neurological impairment, amnestic disorders, low
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intelligence, and affective disorders (Widows & Smith, 2005). When using a sample of
college simulators, Widows and Smith (2005) found that the SIMS exhibited high
sensitivity and specificity with its cut off score of ≥14.
Detection of Feigned Neurocognitive Symptoms
In addition to the SIMS, several other unique detection strategies have been used
in the identification of MND. These measures differ from the typical measures used to
detect malingered psychopathology because they must focus specifically on cognitive
symptoms (Rogers & Bender, 2003).
Reliable Digit Span (RDS; Greiffenstein, Baker, & Gola, 1994) is an internal
validity measure developed from digit span tests found on several common clinical
neurological tests, such as the Wechsler Adult Intelligence Scale-IV (WAIS-IV;
Wechsler, 2008), the Wechsler Memory Scale-IV (WMS-IV; Wechsler, 2009), the
Stanford-Binet-V (SB-V; Roid, 2003), and the Neuropsychological Assessment Battery
(Stern & White, 2003). Individuals may attempt to exaggerate or fabricate their
impairment on digit span tests based on their assumption that the test seems to be one on
which individuals with brain injuries will perform poorly (Meyers & Volbrecht, 1998).
However, individuals with genuine brain dysfunction, even amnesia, tend to have fairly
well preserved the skills needed to complete digit span tasks (Greiffenstein, Baker, &
Gola, 1994). Generally, RDS scores of 7 or lower have been associated with a specificity
of more than 90% in both brain-injured and healthy individuals (Larrabee, 2003; Meyers
& Volbrecht, 1998). Therefore, an RDS score 7 or lower is rarely or never seen in
individuals with genuine brain dysfunction, and scores in this range imply poor effort
and/or response bias (Etherton, Bianchini, Greve, & Heinly, 2005).
14

The Post-Concussive Symptom Questionnaire (PCSQ) is a brief self-report
measure used to evaluate symptom validity among individuals presenting with
neurocognitive complaints. Tsanadis and colleagues (2008) found that the PCSQ was
able to discriminate between individuals with genuine traumatic brain injury and
individuals meeting the criteria for at least probable malingering. Van Dyke and
colleagues (2010) found similar results, showing that the PCSQ measures significant
variance distinct from cognitive performance.
Symptom validity tests (SVT) and their abilities to accurately detect malingering
have been a major focus point within neuropsychology (Bianchini, Mathias, & Greve,
2001). First used to detect exaggerated memory complaints by Pankratz in 1983
(Bianchini, Mathias & Greve, 2001), the use of SVT’s has grown and several different
symptom validity measures have been established. Of those currently used, the first was
the Digit Memory Test (DMT), where an individual is given a string of numbers and later
asked to recognize which string was seen on a forced choice recognition test (Hiscock &
Hiscock, 1989). This format is typical of SVTs; most measures involve forced-choice
recognition tasks over a series of trials (Bickart, Meyer, & Connell, 1991). Very similar
in format to the DMT is the most widely used SVT, the Portland Digit Recognition Test,
which requires the test taker to be able to recognize 72 five-digit strings of numbers
(Binder, 1993). In contrast to the DMT, however, this test has a perceived increase in
difficulty, as it utilizes differing lengths of distracter techniques between trials (Binder,
1993). Again, stemming from the DMT is the Victoria Symptom Validity Test (VSVT),
which is a shortened computerized version of the original Digit Memory Test (Slick,
Hopp, & Strauss, 1995). Finally, differing from the aforementioned SVTs in that it
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involves a picture recognition task, is the Test of Memory Malingering (TOMM;
Tombaugh, 1996). The TOMM has been validated by having high correct response rates
with genuinely neurologically impaired individuals (Tombaugh, 1997), and it is one of
the most comprehensively studied symptom validity tests (Bianchini, Mathias, & Greve,
2001).
Due to the nature of these detection strategies, there are several reasons beyond
malingering that a person could perform below his or her ability level. These reasons can
include genuine cognitive impairment, a comorbid condition such as depression,
expectations of failure, stress, or reactions to inferences from the assessor that his or her
impairment is trivial (Rogers & Bender, 2003). However, the multi-method assessment
approach proposed by Bianchini et al. (2005) assumes individuals indentified as probably
or definite malingering will not be identified as such due to genuine dysfunction or sole
lack of effort. This further necessitates the use of multiple detection measures (selfreport, SVT’s, interviews, etc.)
Detection of Feigned Physical/Somatic Symptoms
Granacher and Berry (2008) suggest that the domain of physical/somatic
malingering has proven to be the most difficult form of malingering to detect. This is
largely due to effects of genuine physical disorders or from the difficulty for clinicians to
differentiate between malingering and a psychological disorder such as conversion or
factitious disorders. Physical/somatic malingering is often presented by an individual as
neurological impairment, however, any physical condition can be malingered (Granacher
& Berry, 2008). When neurological symptoms are reported, typical detection strategies
for neurological malingering can be utilized. For instance, RDS has been found to be
16

effective in detecting malingering amongst individuals reporting pain-related disability
(Etherton, Bianchini, Greve, & Heinly, 2005). Since symptoms presented are not always
neurological, more physical and somatically based measures must be utilized to detect
malingering in this form. In either case, assessors must use detection methods that are
based on non-anatomical or non-physiological presentations of physical disorders
(Granacher & Berry, 2008).
Beyond the use of measures such as SVT’s and various neurological tests in
detecting MPRD, other measures have been found to be effective. One such measure is
the PAI (Morey, 1991). The PAI includes indicators related to somatic symptoms, such
as the Somatic Complaints Scale (SOM), which differentiated pain patients from healthy
respondents (Karlin, Creech, Grimes, Clark, Meagher, & Morey, 2005), along with
several other scales including those which assess depression, anxiety, and treatment
motivation, which have been found to be important in assessing the impact of pain (Turk
& Okifuji, 2002). Hopwood and colleagues (in press) have found that the PAI’s validity
scales have significant effect sizes in differentiating between genuine pain patients and
individuals attempting to feign pain-related symptoms. The researchers also found that
even when simulators were coached on the existence of the validity indicators within the
test, there was a minimal effect on improved ability to feign. Finally, the researchers
found that SOM scale scores were higher for the individuals attempting to feign somatic
symptoms than for individuals with genuine somatic complaints, thus demonstrating the
effectiveness of the PAI in the detection of malingered pain related disability.
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Malingering and the MMPI-2
The MMPI-2 and MMPI-2-RF are two other personality inventories used to detect
malingering across all domains. The MMPI-2 is a 567 true or false self-report
questionnaire that is the most widely used psychological test in the United States
(Graham, 2006). In addition, this measure stands as the most extensively researched
psychological measure of feigned mental disorders (Rogers, Sewell, Martin, & Vitacco,
2003). This measure includes built-in protocol validity scales used to detect inconsistent
responding, random responding, defensiveness, and the over-reporting of symptoms.
The MMPI-2 validity scales used to detect feigning include the F (Infrequency)
scale, Fp (F-Psychiatric) scale, Fb (Back Infrequence) scale, and FBS (Symptom
Validity) scale, along with the more recent addition of the experimental RBS (Response
Bias Scale; Gervais, Ben-Porath, Wygant, & Green, 2007) scale. Extensive research has
been conducted in order to show the validity of these scales in detecting the exaggeration
or fabrication of symptoms. According to Rogers and colleagues (2003), the MMPI-2
employs the rare symptoms, symptom severity, obvious versus subtle symptoms,
symptom selectivity, and erroneous stereotypes strategies within the validity scales aimed
toward the detection of feigning. Most notable of these strategies are the rare symptoms
and erroneous stereotypes approaches.
The rare symptoms approach is a strategy used in the F, Fb, and Fp scales based
on features that are very infrequently reported by genuine clinical populations (Rogers,
2008). This strategy is based upon the assumption that individuals attempting to feign
symptoms will be unable to differentiate between genuine features and these seemingly
appropriate symptoms found within these validity scales. The F and Fb scales were
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created based on the items endorsed by individuals from the normative sample. However,
from a rare symptoms approach, these two scales are limited in that at least fifteen items
on the F scale are endorsed by 25% of individuals from a clinical sample (Greene, 1997).
Therefore, when the F or Fb scale is elevated, it could be due to the feigning of symptoms
however, it could also be a matter of the individual having a genuine psychological
disorder which would cause this scale elevation. It was through the development of the
Fp scale (Arbisi & Ben-Porath, 1995) that this rare symptoms limitation was addressed;
this scale is used to identify rarely endorsed symptoms from a genuine clinical
population. Indeed, it has been found that the F and Fp scales have the largest average
effect sizes in the detection of feigning (Rogers, Sewell, Martin, & Vitacco, 2003; Arbisi
& Ben-Porath, 1995).
Erroneous stereotypes is an approach toward detecting feigning that utilizes items
on the MMPI-2 that individuals attempting to exaggerate or fabricate symptoms would
falsely associate with a certain condition. The development of the FBS scale (Lees-Haley,
English & Glenn, 1991) utilized this erroneous stereotypes strategy in order to provide a
validity measure specific to individuals attempting to feign symptoms within a personal
injury case. Research has later shown that the scale is also effective in the detection of
exaggerated somatic symptoms (Larrabee, 1998, 2003). Although the FBS scale has been
faced with criticism for its narrow focus and possible high false positive rate (e.g. Rogers,
Sewell, Martin, & Vitacco, 2003; Butcher, Arbisi, Atlas & McNulty, 2003), a metaanalysis by Nelson and colleagues (2010) found that the FBS performed as well, if not
better, than other scales used in the detecting the over-reporting of psychological
symptoms. The researchers found that, in particular, the FBS is useful is determining
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effort status and TBI, even finding that the FBS has larger effect sizes in comparison to
other validity scales (F, Fb, and Fp) in these areas. This was shown by Ross and
colleagues (2004) who found that the FBS scale is capable of discriminating between
non-litigating individuals with confirmed traumatic brain injury and litigating individuals
who showed poor effort. Consequently, the Symptom Validity Scale was added to the
official list of scored validity scales on the MMPI-2.
The RBS was designed for the MMPI-2 as a measure specifically developed to
sensitively detect cognitive response bias and predict an individual’s failure on SVT’s
(Gervais, Ben-Porath, Wygant, & Green, 2007). Although FBS scores have been found to
be more elevated by individuals who fail SVT’s than individuals who do not in both
criminal and civil forensic settings (Wygant, Sellbom, Ben-Porath, Stafford, Freeman, &
Heilbronner, 2007), the RBS has been found to be an effective addition to the standard
MMPI-2 validity scales (Gervais, Ben-Porath, Wygant & Green, 2007). RBS scores have
been found to be unlikely to elevate due to genuine memory deficits and its utility
(Gervais, Ben-Porath, Wygant & Green, 2007). Furthermore, the RBS has been found to
be useful in identifying individuals with poor performance on SVT’s as well as
identifying individuals with secondary gain among both criminal and civil forensic
groups (Nelson, Sweet, & Heilbronner, 2007; Wygant, Ben-Porath, Gervais, Sellbom,
Stafford, & Freeman, et al. 2010).
Malingering and the MMPI-2-RF
The MMPI-2-RF is a revised form of the MMPI-2 consisting of 338 true or false
items (Ben-Porath & Tellegen, 2008). Much like its previous version, this measure
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includes built-in protocol validity scales used to detect inconsistent responding, random
responding, defensiveness, and the over-reporting of symptoms.
The MMPI-2-RF uses four over-reporting validity scales, including the F-r
(Infrequent Responses) scale, the Fp-r (Infrequent Psychopathology Responses) scale, the
Fs (Infrequent Somatic Responses) scale, and the FBS-r (Symptom Validity) scale. In
addition, RBS, originally developed for the MMPI-2, can be scored on the MMPI-2-RF
in its entirety. Gervais, Ben-Porath, Wygant, & Green (2007) developed RBS as a scale
indicative of poor performance on cognitive SVT’s and research has been promising
regarding its effectiveness in doing so in both disability (Gervais, Ben-Porath, Wygant,
& Green, 2007; Gervais, Ben-Porath, Wygant, & Green, 2008) and criminal forensic
settings (Wygant, Sellbom, Gervais, Ben-Porath, Stafford, Freeman, & Heilbronner,
2010). Furthermore, RBS was found to outperform the original MMPI-2 validity scales in
predicting poor performance on the TOMM (Whitney, Davis, Shepard, & Herman, 2008).
The Infrequent Somatic Responses (Fs; Wygant, Ben-Porath, & Arbisi, 2004) scale,
designed specifically for the MMPI-2-RF, was developed to measure over-reported
somatic complaints using the traditional infrequency approach. Research by Wygant
(2007) showed that the scale is significantly elevated among samples of individuals who
failed SVT’s and individuals who were instructed to feign somatic symptoms. In
addition, the scale was found to add incrementally to the original MMPI-2 validity scales
in detecting response bias.
Wygant, Gervais, and Ben-Porath (2010) have utilized the MMPI-2-RF in the
study of neurocognitive malingering and the Slick et al. (1999) criteria for detecting
malingered neurocognitive dysfunction. These authors found that over-reporting validity

21

scales were significantly elevated for patients classified in the probable or definite
malingering group in comparison to patients classified as non-malingering. RBS and F-r
were found to have the largest effect sizes in detecting malingering in the neurocognitive
domain. This suggests that the MMPI-2-RF is congruent with the Slick et al. (1999)
criteria in detecting MND. In a similar study, Gervais and colleagues (2010) found that
the overreporting scales and RBS were significantly elevated in a sample of patients with
low performance on measures designed to detect feigned memory complaints.
Furthermore, Youngjohn and colleagues (2011) found that FBS-r accounted for a
significant amount of variance in the detection of individuals who had failed formal effort
tests. These studies, again, confirm the effective utility of the MMPI-2-RF in the
detection of neurocognitive malingering.
The MMPI-2-RF has also been utilized in the detection of over-reported
psychopathology. Sellbom and Bagby (2010) found that the MMPI-2-RF validity scales
(F-r, Fp-r, Fs, and FBS-r) were effective in discriminating between individuals instructed
to feign psychopathology and a known-group of severely mentally-ill psychiatric hospital
patients. In fact, even when simulators were coached on the validity scales on the MMPI2-RF, over-reporting scale scores with the exception of those from FBS-r remained
significantly higher than the scores obtained by the sample of known psychiatric patients.
Specific to the realm of forensic psychology, the MMPI-2-RF has been researched
in regards to the detection of malingering within both criminal and civil forensic settings.
Sellbom and colleagues (2010) found, using a criterion-groups design, that the MMPI-2RF over-reporting validity scales (F-r, Fp-r, Fs, and FBS-r) were effective in detecting
malingered psychopathology among a sample of criminal defendants, with F-r and Fp-r
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producing the largest effect sizes. In a study by Wygant and colleagues (2009), consisting
of a sample of both medical and head injury simulators along with personal injury and
disability claimants, similar positive results were obtained. F-r, Fp-r, and Fs were
significantly elevated for exaggerated neurocognitive symptom groups in comparison to
controls and all over-reporting scales analyzed (F-r, Fp-r, Fs, and FBS-r) were
significantly elevated in the medical symptom exaggeration group in comparison to
controls. Results of these studies show positive results in regards to the use of the MMPI2-RF in detecting malingering across forensic settings and varying domains of
malingering.
The Present Study
The current study investigates the utility of the MMPI-2-RF in the detection of
somatic/physical malingering. While previous studies have shown encouraging results in
regards to the MMPI-2-RF effectively discriminating between individuals who are and
are not malingering, farther research is needed. The present investigation adds to previous
research for several reasons. The participants were classified using the Bianchini et al.
criteria designed specifically for the detection of malingered pain. This expands on
previous research as it eliminates the use of neurocognitive malingering classifications
being utilized in the classification of somatic malingering. In addition, the use of this set
of criteria demands that participants be given a large battery of measures in order to
employ a multi-model strategy of detection. Furthermore, this study uses a known groups
design consisting of disability claimants reporting chronic pain, which improves upon
former studies using college student simulators.
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The purpose of this investigation was to examine the utility of the MMPI-2-RF in
detecting malingering among a sample of individuals classified using criteria for the
detection of malingered pain-related disability. In regards to malingering classification, it
was first hypothesized that each over-reporting scale would be significantly elevated for
participants classified as malingering in comparison to participants classified in a nonmalingering group. In particular, it is hypothesized that F-r and RBS will perform the
best at discriminating between malingering and non-malingering groups, given that
previous research has demonstrated their utility in civil forensic settings (Gervais et al.,
2010; Wygant et al., 2010). However, given the nature of the referral (pain/physical
injuries), it is also anticipated that Fs will exhibit utility in making these classifications,
given that this scales was designed to assess non-credible somatic responding (Tellegen
& Ben-Porath, 2008; Wygant et al., 2009). It is anticipated that Fp-r, which was
developed to measure over-reporting of severe psychopathology, will show the least
utility in classifying litigants in this sample, given the nature of this civil (versus
criminal) setting and this scale was developed to measure exaggerated severe
psychopathology.
In regards to the symptom presentation of the malingering group, it is
hypothesized that individuals who are classified as malingering will have significantly
elevated scores on the Restructured Clinical scales, specifically RC1 (Somatic
Complaints) and RC2 (Low Positive Emotions), both of which should be conceptually
related to pain.
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Chapter II
Method
Participants
This archival sample comprised 169 individuals evaluated by Dr. Robert
Granacher at his forensic neuropsychiatric practice in Lexington, KY between 2001 and
2004 for the purpose of disability determination. Each participant received an evaluation
based on self-reported symptoms of chronic pain. The sample was predominantly male
(68%) and Caucasian (94%) with a mean age of 41.1 (SD = 9.4) and mean education of
11.7 years (SD = 2.3).
Instruments
Self-Report Measures:
MMPI-2-Restructured Form (MMPI-2-RF). Participants were administered the
MMPI-2. However, because this study focuses on the utility of the MMPI-2-RF scales to
detect malingered pain-related disability, the MMPI-2-RF scales were archivally scored
from the full MMPI-2 administration. Previous research has established the equivalence
of scale scores produced with the two versions of the instrument (Tellegen & Ben-Porath,
2008; Van Der Heijden, Egger, & Derksen, 2010).
Structured Inventory of Malingered Symptomatology (SIMS; Widows & Smith,
2005). The SIMS is a self-report measure used to detect malingering consisting of 75
true/false items. The test includes five subscales, including Psychosis (P), Neurologic
Impairment (NI), Amnestic Disorders (AM), Low Intelligence (LI), and Affective
Disorder (AF), each of which assesses a separate domain of symptom exaggeration.
When using a sample of college simulators, Widows and Smith (2005) found that the
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SIMS exhibited a sensitivity of 95% and a specificity of 88% with a cut off score of ≥14.
However, research by Wisdom et al. (2010) in relation to the Slick et al. (1999) criteria
for malingered neurocognitive dysfunction found that the SIMS cutoff of 14 resulted in a
36% false positive rate in the classification of malingering. In fact, these authors found
that a Total Score cutoff of > 23 was necessary for a false positive rate of less than 10%
and a specificity of .55.
Interview-based response bias measures:
Miller Forensic Assessment of Symptoms Test (M-FAST; Miller, 2001). The
Miller Forensic Assessment of Symptoms Test (M-FAST; Miller, 2001) is a structured
25-item screening measure validated to assess for malingered psychopathology. The MFAST includes seven scales, Reported vs. Observed (RO), Extreme Symptomatology
(ES), Rare Combinations (RC), Unusual Hallucinations (UH), Unusual Symptom Course
(USC), Negative Image (NI), and Suggestibility (S). Research by Miller (2001) showed
that in a clinical sample the recommended a cutoff score of 6 for the Total Score
produced a negative predictive power (NPP) of .97, positive predictive power (PPP) of
.68, specificity of .83, and sensitivity of .93. This cutoff score has had similar support in
farther research (Miller, 2004; Guy & Miller, 2004).
Structured Inventory of Reported Symptoms (SIRS; Rogers, Bagby, & Dickens,
1992). The SIRS is a 172-item structured interview designed to capture various overreported response styles. It includes eight primary scale, including Rare Symptoms,
Improbable and Absurd Symptoms, Symptom Combinations, Blatant Symptoms, Subtle
Symptoms, Symptom Severity, Symptom Selectivity, and Reported vs. Observed
Symptoms. Scores are classified into three categories: feigning, indeterminate, and non-
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feigning. Previous studies have illustrated internal consistencies ranging from .77 - .96
for the various scales in addition to having inter-rater reliability ranging from .97 - 1.00
(Rogers, Bagby & Dickens, 1992; Ustad, 1998; Vitacco, Rogers, Gabel, and Munizza,
2007).
Cognitive symptom validity measures:
Test of Memory Malingering (TOMM; Tombaugh, 1996) is a widely used visual
recognition test. The TOMM is one of the most comprehensively studied symptom
validity tests (Bianchini, Mathias, & Greve, 2001) and previous work (Rees, Tombaugh,
Gansler, and Moczynski, 1998) has found the TOMM to produce high sensitivity and
specificity rates in distinguishing between individuals with genuine impairment and
feigning simulators.
Victoria Symptom Validity Test (VSVT; Slick, Hopp, Strauss, & Thompson,
1997). The VSVT is a computerized forced-choice digit recognition test. Performance
falls into three categories: Valid, Questionable, or Invalid. Research by Slick, Hopp,
Strauss, Hunter, and Pinch (1994) using control groups consisting of non-compensationseeking post-concussion patients, and unimpaired participants feigning post-concussion
syndrome found that all control participants performed above cutoffs for malingering
(i.e., 100% specificity). In addition, 83% of the simulators feigning dysfunction scored in
the questionable or invalid range (i.e., 83% sensitivity).
Letter Memory Test (LMT; Inman, Vickery, Berry, Lamb, Edwards, & Smith,
1998). The LMT is a computer administered forced-choice letter recognition test. Inman
and colleagues (1998) found that a performance cut-off of 93% exhibited a sensitivity of
.84 among analogue malingerers, .95 among traumatic brain injury patients with poor
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effort scores on the Digit Memory Test, while exhibiting a specificity of 1.00 for noncompensation seeking neurological patients.
Procedure
Upon completion of the assessment battery, the individual tests were scored
according to their respective manuals and research criteria, which are presented in Table
11. We then grouped participants into one of four classifications based on the Bianchini et
al. (2005) criteria for Malingered Pain Related Disability (MPRD). These criteria
included the presence of external incentive (Criterion A), performance on cognitive
symptom validity tests (Criterion C1-C2), discrepancies between reported and observed
behavior (Criterion D4) and scores on the SIRS, M-FAST, and SIMS for Criterion D5. In
no case could a psychiatric, developmental, or neurological disorder fully account for
classifications of malingering. Therefore, no participants were excluded for Criterion E.
Participants were classified as either Incentive Only (n = 68), Possible Malingering (n =
35), Probable Malingering (n = 55), or Definite Malingering (n = 15).
Statistical Analyses
It was hypothesized that participants in the probable/definite malingering group
actually exaggerate their symptom presentation relative to the non-malingering
participants on the clinically substantive measures of the MMPI-2-RF (Restructured
Clinical scales). To examine this, a one-way multivariate analysis of variance
(MANOVA) was utilized to assess if malingering and non-malingering groups have
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All Tables and Figures can be found in the Appendices.
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significant scale score differences for the Higher Order, Restructured Clinical, and
Somatic/Cognitive Specific Problems scales on the MMPI-2-RF.
To examine whether the scales exhibit significant mean differences across the
various pain malingering classifications, another one-way MANOVA was used.
Finally, classification analyses were conducted to examine the accuracy of
various cut scores for the MMPI-2-RF validity scales in determining the classification of
malingering. In particular, the accuracy of classification was examined in relation to
false positive and false negative classifications of malingering.
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Chapter III
Results
Differential Symptom Presentation
In order to investigate the symptom presentation of individuals who were
malingering, the Restructured Clinical (RC) scales on the MMPI-2-RF were also
evaluated. Differences between the three malingering groups were analyzed using a oneway MANOVA. The overall multivariate analysis of variance (MANOVA) for the three
malingering groups was significant, Wilk’s Lambda = .555, F (18, 324) = 6.154, p <.001.
Six of the nine Restructured Clinical scales were found to differ significantly across all
three of the groups (Incentive Only to Possible, and Possible to Probable/Definite), with
RC3 (Cynicism), RC4 (Antisocial Behavior), and RC9 (Hypomanic Activation) being the
exceptions. Among the three exceptions, however, RC3 and RC4 were found to differ
significantly from the Incentive Only to the Probable/Definite malingering groups.
Interestingly, RC8 (Aberrant Experiences) and RC6 (Ideas of Persecution) were found to
differ between the groups most significantly. Following closely behind, as may be
expected, RCd (Demoralization) and RC1 (Somatic Complaints) were found to have the
third and fourth greatest significant differences, suggesting that individuals classified as
malingering pain endorsed symptoms consistent with feeling sad and unhappy, reporting
multiple somatic complaints, and experiencing unusual thought and perceptual processes
on the MMPI-2-RF. Results of the MANOVA analysis can be seen in Table 4 with the
mean restructured clinical scale profiles presented in Figure 2.
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Validity Scale Malingering Group Differences
Each of the MMPI-2-RF validity scales and RBS were compared across the
malingering classification groups. For the purpose of these analyses, the Probable
Malingering group and Definite Malingering groups were combined due to the small size
of each group. The combination of these two groups in malingering studies has been
utilized in previous work (Greve et al., 2006, Greve et al., 2009; Larrabee, 2003).
A one-way analysis of variance (ANOVA) was conducted in order to determine
the differences in the MMPI-2-RF over-reporting validity scales across each of the three
malingering group classifications. The individual validity scales were then compared
across each group. Each of the over-reporting validity scale scores in the
Probable/Definite Malingering group was significantly higher in comparison to the
scores in the Incentive Only group, which is presented in Table 3. In addition, each overreporting validity scale with the exception of Fp-r there was significantly higher in the
Possible Malingering groups. Mean scores for each of the scales are shown in Figure 1.
Cohen’s d effect size estimates were calculated between the Incentive Only and
Probable/Definite Malingering groups. As hypothesized, RBS rendered the largest effect
(d = 1.67), followed closely by F-r (d = 1.63). Fs and FBS-r also rendered large effect
sizes with d = 1.37 and 1.16, respectively. Finally, not surprisingly given the nature of the
forensic context in this sample, Fp-r was found to have the lowest effect size (d = .93). In
addition, comparisons were made between the Incentive Only and Possible Malingering
groups. Four of the five scales, with Fp-r being the one exception, showed utility in
differentiating between these two groups. Fs was found to have the best utility in
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discriminating between the two groups, followed closely by F-r and RBS. The results of
these analyses are also presented in Table 3.
Classification Accuracy
Table 2 provides the classification accuracy of the MMPI-2-RF over-reporting
validity scales. In addition, this table shows the sensitivity, specificity, and predictive
powers for hypothetical base rates ranging from .10 to .50 for these five scales. The
Incentive Only and Possible Malingering groups were combined and compared with the
Probable/Definite Malingering group for the purpose of these analyses.
In regards to classification accuracy, it was found that lower cutoff scores for the
scales generally yielded good sensitivity, at the loss of specificity. As cutoff scores were
increased, specificity increased. For instance, when analyzing the over-reporting scales at
the lowest cutoff, RBS = 80 and FBS = 80 were found to have excellent sensitivity and
good specificity (.94/.62 and .90/.56, respectively). F-r and Fs were found to render good
sensitivities of .74 and .56, respectively at the lowest cutoffs (F-r = 90 and Fs = 80), with
specificities of .81 and .90. Fp-r was an exception, however, and showed low sensitivity
(.26) with high specificity (.97) at the lowest cutoff (Fp-r = 70). As the cutoffs were
increased, the specificity increased in all cases (naturally, with decreased sensitivities). At
the highest cutoffs, F-r (F-r = 120) had a sensitivity of .30 and specificity of .99, Fp-r
(Fp-r = 100) had a sensitivity of .07 and a specificity of 1.00, Fs (Fs = 100) had a
sensitivity of .26 and a specificity of 1.00, FBS (FBS = 100) had a sensitivity of .16 and
specificity of .99, and RBS (RBS = 100) had a sensitivity of .44 and a specificity of .93.
These results in addition to the sensitivities and specificities at alternate cut-off scores
can be seen in Table 2.
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Given that in clinical settings, psychologists will typically examine the complete
set of validity scales together when reviewing MMPI-2-RF results, the classification
accuracy of the scales was examined together as well. When any one scale was elevated
(regardless of which particular scale was elevated), a sensitivity of .80 and specificity of
.71 was found. When two scales were elevated (again, regardless of which particular
scales were elevated), there was a sensitivity of .88 and specificity of .85. Finally, when
three scales were elevated, a sensitivity of .94 and a specificity of .89 were found. These
results are also exhibited in Table 2.
In addition to analyzing the sensitivities and specificities of each scale, the
positive and negative predictive powers were also evaluated and can also be seen in Table
2. These estimates indicate the malingering classification probability at a certain cut-off.
Due to the fact that estimates of predictive power are heavily influenced by the base-rate
of the condition, positive and negative predictive powers were analyzed at hypothetical
base rates ranging from .10 to .50.
Generally, acceptable positive predictive power (PPP) rates were found with
increased base rates and cut-off scores for these scales. For instance, F-r reached a PPP of
.80 at the lowest cut-off, only when the base rate was set at .50. On the other hand, F-r
reached a PPP of .88 at a base rate of .20, but at the highest cut-off. Similar patterns were
found for both Fp-r and Fs. In the case of FBS-r and RBS, however, it was found that
regardless of the base rate, PPP was not at or above .80 at the lowest cut-offs. In addition,
on RBS, even with a higher cut-off score, a base rate of .40 was still needed in order to
obtain a PPP of at least .80.

33

Chapter IV
Discussion
The current study investigates the association between the MMPI-2-RF overreporting validity scales and structured malingered pain criteria among a sample of civil
litigants claiming symptoms of chronic pain. The purposes of this study was to examine
the utility of the MMPI-2-RF over-reporting validity scales in the classification of
malingered pain disability.
Overall, the over-reporting validity scales of the MMPI-2-RF were found to have
good utility in the detection of malingered pain related disability. Each of the scales was
found to be significantly higher between the Incentive Only and the Probable/Definite
Malingering groups. As expected, RBS and F-r were found to have the greatest effect
sizes in making these comparisons. This is not surprising given the basis for the
construction of each of these scales. In particular, the high performance of RBS was
expected given that the scale was constructed in order to predict the failure of cognitive
SVT’s and the Bianchini et al. (2005) MPRD criteria include performance on SVTs. This
study shows evidence that RBS is in fact performing as intended. Also as hypothesized,
Fp-r had the lowest effect size. This is also not surprising, because individuals in a civil
forensic disability context are not as likely to be presenting symptoms of severe mental
illness (Wygant et al., 2007). In regard to Fs and FBS-r, promising findings were also
obtained. Though the effect sizes were much smaller than those found for F-r and RBS in
this study, both Fs and RBS-r did show utility in distinguishing all three malingering
groups. These results are consistent with previous research of these scales on their use in
civil forensic contexts (Wygant et al., 2009, 2010) which have found the over-reporting
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validity scales to have utility in distinguishing malingering groups among disability
litigants, particularly F-r and RBS. In addition, given that sensitivity and specificity
increased as more than one scale was utilized at a time to make a malingering diagnosis,
this research supports the use of the over-reporting validity scales as a whole. Clinicians
are especially encouraged to use the over-reporting scales of the MMPI-2-RF in
combination with one another in order to assist making malingering determinations. In
terms of classification accuracy, it was generally found that having low cut-off scores
yielded good sensitivity at the loss of specificity. When the cut-off scores were raised,
specificity also rose, but of course at the loss of sensitivity. Since validity scales of the
MMPI-2-RF are intended to be analyzed as a whole, and determinations are not
suggested to be made on the basis of one scale, classification accuracy was found for
multiple scale elevations, which yielded positive findings. When more than one scale was
elevated, high rates were found for both sensitivity and specificity. In terms of cut-off
scores to be used for each of these over-reporting scales, it would be suggested that lower
cut-off scores be utilized in order to increase the sensitivity of the measure. While if the
MMPI-2-RF were being utilized alone in order to classify individuals as malingering or
non-malingering, these lower cut-off scores would render a high rate of false-positives,
the practice of using one measure for malingering determination would be considered
poor clinical judgment. Therefore, it is suggested that the lower cut-off scores of the
over-reporting scales on the MMPI-2-RF be utilized as one piece of evidence in a large
battery of measures used to determine the level of symptom over-reporting. Furthermore,
it is suggested that the MMPI-2-RF be utilized as a screening measure with the use of
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lower cut-off scores in order to determine which individuals need to be tested further for
symptom feigning or magnification.
The hypothesis was generally supported that the Restructured Clinical scales of
the MMPI-2-RF would be significantly elevated in the Probable/Definite Malingering
group in comparison to the Possible Malingering and Incentive Only groups in a
theoretically consistent manner. Eight of the nine scales were found to be significantly
higher in the Probable/Definite Malingering group compared to the Incentive Only group
(with RC9, Hypomanic Activation, being the one exception). This shows that, as would
be expected, and even assumed, those classified as malingering were endorsing a greater
amount of symptoms. Most expectedly, RC1 (Somatic Complaints) was among the scales
with the greatest significant differences between the groups. This finding is not surprising
given that the sample consisted of individuals claiming chronic pain and RC1 includes
items reflecting somatic dysfunction. Also not surprising, RCd was significantly elevated
in the malingering group, suggesting that these litigants were presenting themselves as
depressed, pessimistic, and dejected. Interestingly, RC8 (Aberrant Experiences) exhibited
the largest difference between the groups. This is inconsistent with previous studies (e.g.,
Larrabee, 2003; Wygant et al., 2007), which suggests that disability litigants are unlikely
to report symptoms of severe psychopathology (e.g., psychosis). Further research would
be needed in order to formulate hypotheses for why these results were found, such as
evaluating whether there was a pattern with the malingering individuals elevating this
scale in regards to which specific items were being endorsed.
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Limitations and Future Directions
The current study is not without its limitations. The first of these limitations is
that the present investigation did not include a non-litigating clinical comparison group.
Though there were individuals who were classified as “non-malingering”, these
individuals were not a “no incentive” group as each individual did have a financial
incentive at stake. Since previous research has shown that “no incentive” and “incentive
only” groups can actually differ in their symptom presentation (Bianchini et al., 2008),
this is a limitation of the current study. Future research in regards to the use of multimethod malingered pain detection criteria should utilize a comparison group of
individuals without an incentive to exaggerate their symptoms. An optimal choice for
such group would include a sample of non-litigating chronic pain patients.
In addition, a second limitation of the current study is the lack of a specific
somatic malingering measure administered in the testing battery. This is indeed a
challenge to the field in general, as there are few validated measures used to detect
malingered somatic symptoms, but the present study would have been made stronger had
the few validated measures used for this detection been utilized in this sample. For
instance, future research in this area should use measures such as the Modified Somatic
Perception Questionnaire (MSPQ; Main, 1983) and Waddell’s signs of non-organic pain
(Waddell, McCulloch, Kummel, & Venner, 1980) in order to better validate the use of the
MMPI-2-RF over-reporting validity scales, particularly the Fs scale, in the detection of
malingered pain. Future research in the general field of somatic malingering should also
investigate expanding the options for somatic malingering measures. When a greater
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number of measures are available for this purpose, the study of the MMPI-2-RF in
relation to this topic will be more simple and meaningful.
In conclusion, the results of this study are generally supportive of the use of the
MMPI-2-RF in the detection of malingered pain related disability. A strength of the
present study was the use of the Bianchini et al. Malingered Pain-Related Disability
criteria in order to classify individuals on a continuum of malingering. This gives a more
accurate classification than the use of single response bias criteria, and therefore creates a
more stringent analysis of the MMPI-2-RF over-reporting validity scales. Results were
very promising in that even under the more strict conditions of the structured malingering
criteria, the MMPI-2-RF validity scales performed very well in the classification of
malingering. In addition,the over-reporting validity scales were found to have good
sensitivity and specificity, which support the use of the mMMPI-2-RF in the use of
screening individuals for possible malingering symptomatology. Finally, the hypotheses
put forth were generally supported and it would be expected that the MMPI-2-RF overreporting validity scales will continue to perform well in the use of detecting malingered
pain related disability.
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Table 1
Scoring criteria for response bias measures
Measure

Pass

Below Cutoff

Below Chance

Source

LMT

> 93%

< 93% correct

N/A

Inman et al. (1998)

TOMM

> 90% Trial 2/ Retention

36 - 89.99% (Trial 2/ Retention)

< 36% (Trial 2/ Retention)

TOMM Manual

VSVT

> 30 (Total Correct) or
> 16 (Easy/Difficult Correct)

18 - 29 (Total Correct), or
8 - 15 (Easy/Difficult Correct)

< 17 (Total Correct), or
< 7 (Easy/Difficult Correct)

VSVT Manual

Above Cutoff

Source

M-FAST

> 6Total Score

M-FAST Manual

SIMS

> 23Total Score

Wisdom et al. (2010)

SIRS

> 1 Primary Scale in Definite Range, or > 3 Primary Scales in Probable Range, or Total Score > 76

SIRS Manual

Sources: Inman, T.H., Vickery, C.D., Berry, D.T.R., Lamb, D.G., Edwards, C.L., & Smith, G.T. (1998). Development and initial validation of a
new procedure for evaluating adequacy of effort given during neuropsychological testing: The Letter Memory Test. Psychological
Assessment, 10, 128-139.; Miller, H.A. (2001). Miller Forensic Assessment of Symptoms Test (M-FAST) and professional manual. Lutz,
FL: Psychological Assessment Resources.; Rogers, R., Bagby, R.M., & Dickens, S.E. (1992). Structured Interview of Reported Symptoms
(SIRS) and professional manual. Odessa, FL: Psychological Assessment Resources.; Slick, D.J., Hopp, G., & Strauss, E. (1995). The
Victoria Symptom Validity Test. Odessa, FL: Psychological Assessment Resources.; Tombaugh, T.N. (1996). Test of Memory Malingering
(TOMM). New York: Multi Health Systems.; Wisdom, N., Callahan, J., & Shaw, T. (2010). Diagnostic Utility of the Structured Inventory
of Malingered Symptomatology to Detect Malingering in a Forensic Sample. Archives of Clinical Neuropsychology, 25, 118-125.
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Table 2
Classification Accuracy and Predictive Power (Incentive Only vs. Probable/Definite Malingering)
Predictive Power: Positive/Negative

F-r

Fp-r

Cutoff

SENS

SPEC

90

.74

100

BR

.10

.20

.30

.40

.50

.81

.30/.97

.49/.93

.63/.88

.72/.82

.80/.76

.59

.87

.34/.95

.53/.89

.66/.83

.75/.76

.82/.68

110

.46

.94

.46/.94

.66/.87

.77/.80

.84/.72

.88/.64

120

.30

.99

.77/.93

.88/.85

.93/.77

.95/.68

.97/.59

70

.26

.97

.49/.92

.68/.84

.79/.75

.85/.66

.90/.57

80

.16

.97

.37/.91

.57/.82

.70/.73

.78/.63

.84/.54

90

.13

.99

.59/.91

.76/.82

.85/.73

.90/.63

.93/.53

53

Table 2 (Continued)

Fs

FBS-r

RBS

Cutoff

SENS

SPEC

100

.07

80

BR

.10

.20

.30

.40

.50

1.00

1.00/.91

1.00/.81

1.00/.72

1.00/.62

1.00/.52

.56

.90

.38/.95

.58/.89

.71/.83

.79/.75

.85/.67

90

.46

.96

.56/.94

.74/.88

.83/.81

.88/.73

.92/.64

100

.26

1.00

1.00/.92

1.00/.84

1.00/.76

1.00/.67

1.00/.57

80

.90

.56

.19/.98

.34/.96

.47/.93

.58/.89

.67/.85

90

.47

.82

.22/.93

.39/.86

.53/.78

.64/.70

.72/.61

100

.16

.99

.64/.91

.80/.83

.87/.73

.91/.64

.94/.54

80

.94

.62

.22/.99

.38/.98

.51/.96

.62/.94

.71/.91

90

.74

.82

.31/.97

.51/.93

.64/.88

.73/.83

.80/.76
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Table 2 (Continued)
Cutoff

SENS

SPEC

100

.44

BR

.10

.20

.30

.40

.50

.93

.41/.94

.61/.87

.73/.79

.81/.71

.86/.62

Multiple

1 Elevation

.80

.71

.23/.97

.41/.93

.54/.89

.65/.84

.73/.78

Scales

2 Elevations

.88

.85

.39/.98

.59/.97

.72/.94

.80/.91

.85/.88

3 Elevations

.94

.89

.49/.99

.68/.98

.79/.97

.85/.96

.90/.94

Note. MND = Malingered Neurocognitive Dysfunction. SENS = Sensitivity, SPEC = Specificity, BR = Hypothetical Base
Rate. Multiple Scales utilized a combination of scales and considered an individual to be classified as malingering if F-r >
95, Fp-r > 70, Fs > 90, FBS-r > 90, or RBS > 90.
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Table 3
MMPI-2-RF validity scales and criteria for Malingered Pain Related Disability
Malingered Pain Related Disability Classification
Incentive

Possible

Probable/Definite

Only

Malingering

Malingering

(n = 68)

(n = 34)

(n = 67)

M

SD

M

SD

M

ANOVA
SD

Effect Size

F (2,166)

p

d

F-r

72.46a 19.078

86.78b

20.101

106.73c

22.835

45.82

<.001

.36

1.63

FP-r

51.91a 10.277

57.69a

12.921

64.93b

16.993

15.03

<.001

.07

0.93

FS

59.63a 13.792

75.69b

18.072

85.32c

22.761

32.45

<.001

.28

1.37

FBS-r

75.26a 14.281

84.03b

14.181

90.01b

10.834

21.90

<.001

.21

1.16
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Table 3 (Continued)
M
RBS

SD

72.61a 17.224

M

SD

M

SD

87.07b

14.292

98.51c

13.549

F (2,166)

p

48.67

<.001

d
.37

1.67

Note. Means for all three groups were significantly different for each scale (Tukey HSD). F-r = Infrequent Responses; FP-r =
Infrequent Psychopathology Responses; FS = Infrequent Somatic Responses; FBS-r = Symptom Validity. RBS = Response Bias Scale.
Cohen’s d calculated between Incentive Only and Probable/Definite Malingering groups.

58

APPENDIX D:
MMPI-2-RF Restructured Clinical Scales and Criteria for MPRD

59

Table 4
MMPI-2-RF restructured clinical scales and criteria for Malingered Pain Related Disability
Malingered Pain Related Disability Classification
Incentive

Possible

Probable/Definite

Only

Malingering

Malingering

(n = 68)

(n = 35)

(n = 70)

M

SD

M

SD

M

ANOVA
SD

F (2,162)

p

d

RCd

65.51a 11.024

71.23b

11.892

77.99c

6.392

28.97

<.001

1.13

RC1

72.40a 12.955

81.29a

11.834

86.86b

9.657

27.57

<.001

1.12

RC2

70.10a 13.020

75.89b

13.286

84.21c

10.875

23.05

<.001

1.08

RC3

53.90a 12.633

55.80ab

11.852

60.90b

11.975

5.92

.003

0.55
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Table 4 (Continued)

RC4

M

SD

47.97a

8.760

M
47.00 ab

SD

M

SD

10.224

51.90b

10.836

F (2,162)

p

d

3.94

.021

0.45

RC6

52.82a

10.172

57.54a

12.668

67.97b

15.592

23.78

<.001

1.49

RC7

56.69a

11.970

63.34b

13.647

69.96c

11.862

20.12

<.001

1.11

RC8

49.76a

10.512

56.83b

14.537

67.83c

14.344

33.60

<.001

1.72

RC9

43.85a

8.706

44.20a

11.631

46.43a

10.182

1.29

.279

0.30

Note. RCd = Demoralization; RC1 = Somatic Complaints; RC2 = Low Positive Emotions; RC3 = Cynicism; RC4 = Antisocial
Behavior; RC6 = Ideas of Persecution; RC7 = Dysfunctional Negative Emotions; RC8 = Aberrant Experiences; RC9 = Hypomanic
Activation. Cohen’s d calculated between Incentive Only and Probable/Definite Malingering groups.

61

APPENDIX E:
Mean Over-Reporting Validity Scale Score
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Figure 1. Mean Over-Reporting Validity Scale Scores
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APPENDIX F:
Mean Restructured Clinical Scale Scores
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Figure 2. Mean Restructured Clinical Scale Scores
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